Abstract
Clinical success in treating transplant rejection to date has been achieved primarily through the development increasingly potent immunosuppressive drugs to inhibit immune responses. These approaches require life-long treatment and suppress the entire immune system non-specifically exposing the patient to increased risks of cancer and infection. Even then long-term graft survival is not guaranteed. Evidence that regulatory T cells can control rejection and facilitate the development of specific unresponsiveness to alloantigens in vivo has been accumulating over many years. Understanding how the immune system is controlled by regulatory T cells when it responds to alloantigen and promoting the development of cells that can regulate immune responses holds the key to the development of more selective therapies that target only destructive immune responses while leaving the beneficial protective functions of the immune system intact.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Billingham, R.E., L. Brent, and P.B. Medawar. 1953. Actively acquired tolerance of foreign cells. Nature 172:603–606.
Billingham, R.E., L. Brent, and P.B. Medawar. 1956. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos trans R Soc Lond B 239:357–412.
Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J Immunol 155:1151–1164.
Suri-Payer, E., A. Amar, A. Thornton, and E. Shevach. 1998. CD4+CD25+T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212–1218.
Baecher-Allan, C., J. Brown, G. Freeman, and D. Hafler. 2001. CD4+ CD25+ high regulatory cells in human peripheral blood. J Immunol 167:1245–1253.
Stephens, L., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31: 1247–1254.
Hara, M., C. Kingsley, M. Niimi, S. Read, S. Turvey, A. Bushell, P. Morris, F. Powrie, and K. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166:3789–3796.
Thorstenson, K., and A. Khoruts. 2001. Generation of anergic and potentially immunoregulatory CD25+CD4+ T cells in vivo after induction of peripheral tolerance with intravenous oral antigen. J Immunol 167:188–195.
Kingsley, C.I., M. Karim, A.R. Bushell, and K.J. Wood. 2002. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168:1080–1086.
Apostolou, I., and H. Von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401–1408.
Cobbold, S.P., R. Castejon, E. Adams, D. Zelenika, L. Graca, S. Humm, and H. Waldmann. 2004. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 172:6003–6010.
Marangoni, F., S. Trifari, S. Scaramuzza, C. Panaroni, S. Martino, L.D. Notarangelo, Z. Baz, A. Metin, F. Cattaneo, A. Villa, A. Aiuti, M. Battaglia, M.-G. Roncarolo, and L. Dupre. 2007. WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells. J Exp Med 204:369–380.
Long, E., and K.J. Wood. 2007. Understanding FOXP3: progress towards achieving transplantation tolerance. Transplantation 84:459–461.
Williams, L., and A. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8:277–284.
Wan, Y., and R. Flavell. 2007. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445:766–770.
Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J.K. Polansky, K. Schlawe, H.-D. Chang, T. Bopp, E. Schmitt, S. Klein-Hessling, E. Serfling, A. Hamann, and J. Huehn. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLOS Biol 5:169–178
Bushell, A., P. Morris, and K. Wood. 1995. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 25:2643–2649.
Warnecke, G., A. Bushell, S. Nadig, and K.J. Wood. 2007. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo. Transplantation 83:1459–1465.
Koshiba, T., T. Kitade, and B. Van Damme. 2003. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 76:588–596.
Weaver, C., L. Harrington, P. Mangan, M. Gavrieli, and K. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688.
Wells, A., X. Li, Y. Li, M. Walsh, X. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. Hancock, T. Strom, and L. Turka. 1999. Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5:1303–1307.
Adams, A., M.A. Williams, T. Jones, N. Shiasugi, M.M. Durham, S. Kaech, E. Wherry, T. Onami, J. Lanier, K. Kokko, T. Pearson, R. Ahmed, and C.P. Larsen. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111:1887–1895.
Yang, J., M. Brook, M. Carvalho-Gaspar, J. Zhang, H. Ramon, M. Sayegh, K. Wood, L. Turka, and N. Jones. 2007. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 104:19954–19959.
Tang, Q., J. Adams, A. Tooley, M. Bi, B. Fife, P. Serra, P. Santamaria, R. Locksley, M. Krummel, and J. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83–92.
Veldhoen, M., R. Hocking, C. Atkins, R. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189.
Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. Strom, M. Oukka, H. Weiner, and V. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238.
Pratschke, J., M.J. Wilhelm, I. Laskowski, M. Kusaka, F. Beato, S.G. Tullius, P. Neuhaus, W.W. Hancock, and N.L. Tilney. 2001. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 12:2474–2481.
Weiss, S., K. Kotsch, M. Francuski, A. Reutzel-Selke, L. Mantouvalou, R. Klemz, O. Kuecuek, S. Jonas, C. Wesslau, F. Ulrich, A. Pascher, H.D. Volk, S.G. Tullius, P. Neuhaus, and J. Pratschke. 2007. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 7:1584–1593.
Pratschke, J., D. Paz, M. Wilhelm, I. Laskowski, G. Kofla, A. Vergopoulos, H. MacKenzie, S. Tullius, P. Neuhaus, W.W. Hancock, H.-D. Volk, and N. Tilney. 2004. Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts. Transplantation 77:43–48.
Chen, Y., and K.J. Wood. 2007. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation 84:1071–1074.
van Maurik, A., K.J. Wood, and N. Jones. 2002. Cutting edge:CD4(+)CD25(+) alloantigen-specific immunoregulatory cells that can prevent CD8(+) T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 169:5401–5404.
Li, Y., T. Koshiba, A. Yoshizawa, Y. Yonekawa, K. Masuda, A. Ito, M. Ueda, T. Mori, H. Kawamoto, Y. Tanaka, S. Sakaguchi, N. Minato, K.J. Wood, and K. Tanaka. 2004. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4:2118–2125.
Martinez-Llordella, M., I. Puig-Pey, G. Orlando, M. Ramoni, G. Tisone, A. Rimola, J. Lerut, D. Latinne, C. Margarit, I. Bilbao, S. Brouard, M. Hernandez-Fuentes, J.P. Soulillou, and A. Sanchez-Fueyo. 2007. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7:309–319.
Graca, L., S.P. Cobbold, and H. Waldmann. 2002. Identification of Regulatory T Cells in Tolerated Allografts. J Exp Med 195:1641–1646.
Mempel, T.R., M. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. Von Boehmer, and U.H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25:129–141.
Akl, A., N.D. Jones, N. Rogers, M.A. Bakr, A. Mostafa, E.L.M. El Shehawy, M.A. Ghoneim, and K.J. Wood. 2008. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int 21:65–73.
Frasca, L., C. Scotta, G. Lombardi, and E. Piccolella. 2002. Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J Immunol 168:1060–1068.
Vendetti, S., J.-G. Chai, J. Dyson, E. Simpson, G. Lombardi, and R. Lechler. 2000. Anergic T cell sinhibit the antigen presenting funciton of dendritic cells. J Immunol 165:1175–1181.
Cederbom, L., H. Hall, and F. Ivars. 2000. CD4+CD25+ regulatory T cells down-regulate costimulatory molecules on antigen presenting cells. Eur J Immunol 30:1538–1543.
Tadokoro, C.E., G. Shakhar, S. Shen, Y. Ding, A.C. Lino, A. Maraver, J.J. Lafaille, and M.L. Dustin. 2006. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 203:505–511.
Lin, C.-Y., L. Graca, S.P. Cobbold, and H. Waldmann. 2002. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol 3:1208–1213.
Jones, N.D., M. Carvalho-Gaspar, S. Luo, M.O. Brook, L. Martin, and K.J. Wood. 2006. Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol 176:2316–2323.
Grossman, W., J. Verbsky, W. Barchet, M. Colonna, J. Atkinson, and T. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589–601.
Gondek, D.C., L.-F. Lu, S.A. Quezada, S. Sakaguchi, and R.J. Noelle. 2005. Cutting edge: Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174:1783–1786.
Kreisel, D., A. Krupnick, A. Gelman, F. Engels, S. Popma, A. Krasinskas, K. Balsara, W. Szeto, L. Turka, and B. Rosengard. 2002. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 8:233–239.
Choo, J., J. Seebach, V. Nickeleit, A. Shimizu, H. Lei, D. Sachs, and J. Madsen. 1997. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium. Transplantation 64:1315–1322.
Thornton, A., and E.M. Shevach. 2000. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol 164:183–190.
Karim, M., G. Feng, K.J. Wood, and A. Bushell. 2005. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen specific reactivation in vivo is critical for bystander regulation. Blood 105:4871–4877.
Vukmanovic-Stejic, M., Y. Zhang, J. Cook, J. Fletcher, A. McQuaid, J. Maters, M.H. Rustin, L. Taams, P. Beverley, D. Macallan, and A.N. Akbar. 2006. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116:2423–2433.
Sawitzki, B., C.I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K.J. Wood. 2005. Interferon gamma production by alloantigen reactive CD25+CD4+ regulatory T cells is important for their regulatory function in vivo. J Exp Med 201:1925–1935.
Sawitzki, B., A. Bushell, U. Steger, N. Jones, K. Risch, A. Siepert, M. Lehmann, I. Schmitt-Knosalla, K. Vogt, I. Gebuhr, K. Wood, and H.D. Volk. 2007. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 7: 1091–1102.
Hassanain, H.C., SY, and S. Gupta. 1993. Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-γ and α:analysis of the regulatory region of the gene and identification of an interferon-γ inducible DNA binding factor. J Biol Chem 268:5077–5084.
Orabona, C., P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallorino, R. Bianchi, E. Velardi, K. Perrucio, A. Verlardi, V. Bronte, M. Fioretti, and U. Grohmann. 2006. Towards the identification of a tolerogenic signature of IDO competent dendritic cells. Blood 107:2846–2854.
Grohmann, U., C. Orabona, F. Fallorino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. Belladonna, R. Bianchi, M. Fioretti, and P. Puccetti. 2002. CTLA-4Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097–1101.
Mellor, A., D. Keskin, T. Johnson, P. Chandler, and D. Munn. 2002. Cells expressing 2,3-dioxygenase inhibit T cell responses. J Immunol 168:3771–3776.
Terness, P., T. Bauer, L. Rose, C. Dufter, A. Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196: 447–457.
Beutelspacher, S., R. Pillai, M. Watson, P. Tan, J. Tsang, M. McClure, A. George, and D. Larkin. 2006. Function of indole-amine 2,3-dioxygensae in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 36:690–700.
Billiau, A., H. Heremans, F. Vandekerckhove, R. Dijkmans, H. Sobis, E. Meulepas, and H. Carton. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140:1506–1510.
Kelchtermans, H., B. De Klerck, T. Mitera, M. Van Balen, D. Bullens, A. Billiau, G. Leclercq, and P. Matthys. 2005. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther 7:R402–R415.
Irmler, I.M., M. Gajda, and R. Brauer. 2007. Exacerbation of antigen-induced arthritis in IFN-{gamma}-deficient mice as a result of unrestricted IL-17 response. J Immunol 179:6228–6236.
Wood, K.J., and B. Sawitzki. 2006. Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends in Immunology 27:183–187.
Konieczny, B., Z. Dai, E. Elwood, S. Saleem, P. Linsley, F. Baddoura, C. Larsen, T. Pearson, and F. Lakkis. 1998. IFN-g is critical for long-term allograft survival indcued by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160:2059–2064.
Yu, X.-Z., M.H. Albert, P.J. Martin, and C. Anasetti. 2004. CD28 ligation induces transplantation tolerance by IFN-{gamma}_dependent depletion of T cells that recognize alloantigens. J Clin Invest 113:1624–1630.
Saleem, S., B. Konieczny, R. Lowry, F. Baddoura, and F. Lakkis. 1996. Acute rejection of vascularized heart allografts in the absence of IFNγ. Transplantation 62:1908–1911.
Markees, T., N. Phillips, E. Gordon, R. Noelle, L. Shults, J. MOrdes, D. Greiner, and A. Rossini. 1998. Long term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomised mice requires CD4+ T cells, interferon-γ and CTLA-4. J Clin Invest 101:2446–2455.
O'Garra, A. 1998. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 8:275–283.
Gajewski, T.F., and F.W. Fitch. 1988. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN- gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245–4252.
Tewari, K., Y. Nakayama, and M. Suresh. 2007. Role of Direct Effects of IFN-{gamma} on T Cells in the Regulation of CD8 T Cell Homeostasis. J Immunol 179:2115–2125.
Thompson, C., and J. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445–450.
Walunas, T., D. Lenschow, C. Bakker, P. Linsley, G. Freeman, J. Green, C. Thompson, and J. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405–413.
Waterhouse, P., J. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. Lee, C. Thompson, H. Griesser, and T. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985–988.
Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimuzu, N. Sakaguchi, T. Mak, and S. Sakaguchi. 2000. Immunologic self tolerance is maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte associated antigen 4. J Exp Med 192:303–310.
Read, S., V. Malmstrom, and F. Powrie. 2000. Cytotoxic T lymphocyte associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192:295–302.
Azimzadeh, A.M., S. Pfeiffer, G. Wu, C. Schroder, G.L. Zorn, 3rd, S.S. Kelishadi, E. Ozkaynak, M. Kehry, J.B. Atkinson, G.G. Miller, and R.N. Pierson, 3rd. 2006. Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms. Transplantation 81:255–264.
Fallarino, F., U. Grohmann, K. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. Belladonna, M. Fioretti, M. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4:1206–12012.
Schneider, H., E. Valk, S. da Rocha, B. Wei, and C. Rudd. 2005. CTLA-4 upregulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternative basis for co-receptor function. Proc Natl Acad Sci USA 102:12861–12866.
Schneider, H., J. Downey, A. Smith, B.H. Zinselmeyer, C. Rush, J.M. Brewer, B. Wei, N. Hogg, P. Garside, and C.E. Rudd. 2006. Reversal of the TCR Stop Signal by CTLA-4. Science 313:1972–1975.
Li, L., R.J. Greenwald, E.M. Lafuente, D. Tzachanis, A. Berezovskaya, G.J. Freeman, A.H. Sharpe, and V.A. Boussiotis. 2005. Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo. J Immunol 175:3133–3139.
Hernandez-Fuentes, M., A. Warrens, and R. Lechler. 2003. Immunological monitoring. Immunol Rev 196:247.
Soulillou, J.P. 2001. Immune monitoring for rejection of kidney transplants. N Engl J Med 344:1006.
Stordeur, P., L. Zhou, and M. Goldman. 2002. Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods 261:195.
Sarwal, M., M. Chua, and N. Kambham. 2003. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349:125.
Brouard, S., E. Mansfield, C. Braud, L. Li, M. Giral, S.-c. Hsieh, D. Baeten, M. Zhang, J. Ashton-Chess, C. Braudeau, F. Hsieh, A. Dupont, A. Pallier, A. Moreau, S. Louis, C. Ruiz, O. Salvatierra, J.-P. Soulillou, and M. Sarwal. 2007. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci 104:15448–15453.
Mueller, T.F., J. Reeve, G.S. Jhangri, M. Mengel, Z. Jacaj, L. Cairo, M. Obeidat, G. Todd, R. Moore, K.S. Famulski, J. Cruz, D. Wishart, C. Meng, B. Sis, K. Solez, B. Kaplan, and P.F. Halloran. 2008. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 8:78–85.
Nickel, P., J. Lacha, and S. Ode-Hakim. 2001. Cytotoxic efector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation 72:1158.
Sabek, O., M. Dorak, M. Kotb, A.O. Gaber, and L. Gaber. 2002. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 74:701.
Shulzhenko, N., A. Morgun, and X. Zheng. 2001. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Transplantation 72:1705.
Strehlau, J., M. Pavlakis, M. Lipman, W. Maslinski, M. Shaprio, and T. Strom. 1996. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 46:30.
Li, B., C. Hartono, and R. Ding. 2001. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344:947.
Simon, T., G. Opelz, M. Wiesel, R. Ott, and C. Susal. 2003. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 3:1121.
Saiura, A., C. Mataki, and T. Murakami. 2001. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 72:320.
Akalin, E., R. Hendrix, and R. Polavarapu. 2001. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 72:948.
Flechner, S., S. Kurian, and S. Head. 2004. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4:1475.
Scherer, A., A. Krause, J. Walker, A. Korn, D. Niese, and F. Raulf. 2003. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 75:1323.
Deng, M., H.J. Eisen, and M. Mehra. 2006. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6:150.
Hoffmann, S., D.A. Hale, and D. Kleiner. 2005. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 5:573.
Kosuge, T., T. Tamura, H. Nariuchi, and S. Toyoshima. 2000. Effect of inhibitors of glycoprotein processing on cytokine secretion and production in anti-CD3 stimulated T cells. Biol Pharm Bull 23:1–5.
Demetriou, M., M. Granovsky, S. Quaggin, and J. Dennis. 2001. Negative regulation of T cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733–739.
Dennis, J., J. Pawling, P. Cheung, E. Partridge, and M. Demetriou. 2002. UDP-N-acetyl- glucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochem Biophys Acta 1573:414.
Morgan, R., G. Gao, J. Pawling, J. Dennis, M. Demetriou, and B. Li. 2004. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 173:7200.
Cobbold, S.P., K. Nolan, and L. Graca. 2003. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 196:109.
Zelenika, D., E. Adams, S. Humm, L. Graca, S. Thompson, S.P. Cobbold, and H. Waldmann. 2002. Regulatory T cells overexpress a subset of Th2 gene transpcripts. J Immunol 168:1069–1079.
Matsui, Y., A. Saiura, and Y. Sugawara. 2003. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiol Genomics 15:199.
Louvet, C., E. Chiffoleau, and M. Heslan. 2005. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant 5:2143.
Metcalfe, S., and D. SMPA. 2005. Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection. Int Immunopharmacol 5:33.
Tan, J.T., B. Ernst, W.C. Kieper, E. LeRoy, J. Sprent, and C.D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 195:1523–1532.
Murakami, M., A. Sakamoto, J. Bender, J. Kappler, and P. Marrack. 2002. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci 99:8832–8837.
Pearl, J.P., J. Parris, D.A. Hale, S.C. Hoffmann, W.B. Bernstein, K.L. McCoy, S.J. Swanson, R.B. Mannon, M. Roederer, and A.D. Kirk. 2005. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5:465–474.
Trzonkowski, P., M. Zilvetti, P. Friend, and K.J. Wood. 2006. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation 82:1342–1351.
Valujskikh, A., B. Pantenburg, and P.S. Heeger. 2002. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2:501–509.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wood, K.J. et al. (2008). Regulatory T Cells in Transplantation. In: Jiang, S. (eds) Regulatory T Cells and Clinical Application. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77909-6_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-77909-6_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77908-9
Online ISBN: 978-0-387-77909-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)